Panacea Biotec Ltd said its first quarter net profit rose 150% to Rs32.6 crore compared with Rs13 crore during the June quarter of previous year.
During the period its total revenues increased to Rs253.9 crore, a growth of 43%, from Rs177.2 crore, same quarter a year ago, it said in a regulatory filing.
On Wednesday, Panacea Biotec shares rose 2.8% at Rs198 on the Bombay Stock Exchange, while the Sensex closed 0.6% up at 17,977 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
